CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-28 | Bolzon Bradley J PhD Director | Sale | −2,281 | $154.57 | $353K | 817 |
| 2021-06-28 | Bolzon Bradley J PhD Director | Sale | −1,119 | $154.57 | $173K | 159,232 |
| 2021-06-28 | Bolzon Bradley J PhD Director | Sale | −268 | $155.27 | $42K | 549 |
| 2021-06-28 | Bolzon Bradley J PhD Director | Sale | −132 | $155.27 | $20K | 159,100 |
| 2021-06-28 | Bolzon Bradley J PhD Director | Sale | −549 | $156.54 | $86K | 0 |
| 2021-06-28 | Bolzon Bradley J PhD Director | Sale | −269 | $156.54 | $42K | 158,831 |
| 2021-06-21 | Novak Rodger President | Sale | −1,171 | $125.58 | $147K | 646,836 |
| 2021-06-21 | Novak Rodger President | Sale | −881 | $126.62 | $112K | 645,955 |
| 2021-06-21 | Novak Rodger President | Sale | −2,969 | $127.71 | $379K | 642,986 |
| 2021-06-21 | Novak Rodger President | Sale | −12,630 | $128.76 | $1.6M | 630,356 |
| 2021-06-21 | Novak Rodger President | Sale | −7,299 | $129.46 | $945K | 623,057 |
| 2021-06-21 | Novak Rodger President | Sale | −50 | $130.27 | $7K | 623,007 |
| 2021-06-15 | Kulkarni Samarth Chief Executive Officer | Option exercise | +30,000 | $12.57 | $377K | 217,719 |
| 2021-06-15 | Kulkarni Samarth Chief Executive Officer | Sale | −10,383 | $125.39 | $1.3M | 207,336 |
| 2021-06-15 | Kulkarni Samarth Chief Executive Officer | Sale | −16,129 | $126.86 | $2.0M | 191,207 |
| 2021-06-15 | Kulkarni Samarth Chief Executive Officer | Sale | −3,488 | $127.51 | $445K | 187,719 |
| 2021-06-15 | Kulkarni Samarth Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −30,000 | 63,333 | ||
| 2021-06-11 | Bolzon Bradley J PhD Director | Sale | −5,427 | $125.62 | $682K | 24,948 |
| 2021-06-11 | Bolzon Bradley J PhD Director | Sale | −1,918 | $126.59 | $243K | 23,030 |
| 2021-06-11 | Bolzon Bradley J PhD Director | Sale | −800 | $127.88 | $102K | 22,230 |
Page 28 of 46 · 910 trades